Post-earnings recap
Reported
Tue, May 14, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report indicates that Immunome Inc is struggling with significant losses, as reflected in the EPS figure. The stock reacted negatively, dropping 5.7% after the announcement. Investors may be concerned about the lack of revenue data and the absence of guidance for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-2.51 | N/A | -213.75% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concerns about the current financial performance. They highlighted the importance of adapting strategies to improve results.
Management acknowledged the challenges faced in the quarter.
They emphasized the need for strategic adjustments moving forward.